Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ther is going to be #1 for FDA approved drugs to identify for cancer
Lstest news
cancer test available ...approved by medicaid/medicare and private insurance...
They have hire new directors and coo who has tremendous knowledge
I think time to hold and with the news it can hit back...
Buy
THERALINK TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
SEPTEMBER 30, 2022 AND 2021
NOTE 13 – SUBSEQUENT EVENTS
Private Placement Offering
On November 29, 2022, the Company consummated the initial closing (the “Initial Closing”) of a private placement offering (the “Offering”) pursuant to the terms and conditions of that certain Securities Purchase Agreement, dated as of November 29, 2022 (the “Purchase Agreement”), by and among the Company, certain accredited investors (the “Purchasers”) and Cavalry Fund I Management LLC, a Delaware limited liability company, in its capacity as collateral agent (the “Collateral Agent”). At the Initial Closing, the Company sold the Purchasers (i) 10% Original Issue Discount Senior Secured Convertible Debentures (the “Debentures”) in an aggregate principal amount of $3,355,000 and (ii) warrants (the “Warrants” and together with the Debentures, the “Underlying Securities”) to purchase up to 958,571,426 shares of common stock of the Company (the “Common Stock”), subject to adjustments provided by the Warrants, which represents 100% warrant coverage. The Company received a total of $2,639,000 in net proceeds at the Initial Offering, net of the Original Issue Discount of $305,000, commissions of $305,000 and other offering costs of $106,000. The company also incurred offering costs of $27,270 which were reflected as deferred offering costs as of September 30, 2022. In November 2022, additional offering costs of $32,000 were incurred.
The Company may hold one or more subsequent closings at any time prior to December 31, 2022, unless otherwise extended, to sell additional Underlying Securities in an aggregate principal amount up to $6,600,000, which may be adjusted upward to mean an aggregate principal amount of $8,000,000 upon written consent of the Company and the Placement Agent (as defined below).
The Purchase Agreement contains customary representations, warranties, and covenants of the Company, including, among other things and subject to certain exceptions, covenants that restrict the ability of the Company without the prior written consent of the Debenture holders, to incur additional indebtedness, and repay outstanding indebtedness, create or permit liens on assets, redeem its Common Stock, settle outstanding litigation, or enter into transactions with affiliates.
Ther good news
Its going to cross 3 to 5 cents
Dont worry ..they would jump up with one news..it should be up to 10 cents
Check 52 week, and now we have so many good news about it
Merger ot take over soon
Please note: this article references that Colorado-based Theralink Technologies, Inc. has a commercially available quantitative HER2 assay that appears to provide a more accurate assessment. This opens the door for Theralink to perhaps help tens of thousands or more women who will probably need the Theralink test to determine if they are truly HER2Low or not-- and provide insights and recommendations for treatment selection.”
We hope you find the article as interesting of a read as we did!
https://www.reuters.com/business/healthcare-pharmaceuticals/patient-selection-astrazeneca-daiichi-breast-cancer-drug-needs-improvement-2022-12-09/
Sthc is going current
News are comimg out soon
Lets hipe it goes to 10 cents
Check tesla or google they have too
Ther can go back to dollar ..ytd
So.many good news
https://www.prnewswire.com/news-releases/theralink-technologies-appoints-seasoned-commercial-leader-faith-zaslavsky-as-president--chief-operating-officer-for-its-precision-oncology-company-301695186.html
Sthc
Going to be active in Dec 2022
With merger its going to biggest in graphite and EV futures
Nasdaq listings...in 2023
Going to be dollar...and above
$ther
Ther can go back to dollar with so many good news
Buy ther
https://www.prnewswire.com/news-releases/theralink-technologies-achieves-the-first-college-of-american-pathologists-accreditation-for-a-commercial-reverse-phase-protein-array-laboratory-in-us-301686459.html
Buy Ther
Ther can be take over or go back to dollar soon
Buy now
https://www.prnewswire.com/news-releases/theralink-technologies-achieves-the-first-college-of-american-pathologists-accreditation-for-a-commercial-reverse-phase-protein-array-laboratory-in-us-301686459.html
Ther can be big takeover or go back to dollar soon with merger with so many good news for cancer assay
https://www.prnewswire.com/news-releases/theralink-technologies-achieves-the-first-college-of-american-pathologists-accreditation-for-a-commercial-reverse-phase-protein-array-laboratory-in-us-301686459.html
Good news will come soon...results from collaborations with avera cancer
https://www.avera.org/news-media/news/2022/avera-health-and-theralink-technologies-announce-collaboration/
Strong buy
Yes, but who would invest 1 million if the compsny is not doing great..snd they are the officers and directors
I think you should get out of this post
Good news with 8k filled...1 million dollars investments
Great cancer assay with great help to the patients who can be most beneficial..to chek if the med works or not..its great company with so much expertise and research
Strong buy
https://last10k.com/sec-filings/ther/0001493152-22-026023.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ther
Good news for STHC
$STHC Ameca Ltd. Ore Body Offtake There are two parts to the Ameca project. The first is the Offtake Agreement pursuant to which the Company will act as a reseller of the graphite concentrate. The Offtake Agreement with Ameca requires the Company to purchase a minimum of 10,000 m/t year on the express condition that the graphite produced from the property is greater than 180 microns in size. As the mining development industry in Sri Lanka has been shutdown due to the COVID 19 pandemic, operation of Amecas mine in Sri Lanka has been delayed past the previously announced schedule of late 2021 or early 2022 which was stated in the October 2020 press release. Amecas mine is now expected to ramp up in 2023. The second part of the project is for the Company to provide Air Classifiers to Ameca to process the graphite ore in Sri Lanka
once Its listed back soon will go to 30 to 50 cents Strong upcoming company with lots of potential.
Good news are many but behind the scene, within company insiders
Good news coming with the investor conference happen in newyork from.sept12 till sept 14
Investors are definately excited about cancer Assay which would help.lots of patients who has cancer
Going to be bsck to.dollar
Strong bye
Check the news and latest quarterly report
It would jump 10 to 20 cents
Strong buy now
Good news 2 new patent for cancer...
Merger coming soon...will go back to 50 cents to $1
As in last past 6months
Rnva...huge news , jump to 2 to 5 cents in few dayd
Check 3 months share price
RNVA$$$$
Its not approved and they are not going to increase 100,000,0000
https://theralink.com/media-articles#
Video to check for uplksting ther to nasdaq and also bringing
Revenue with cancer assay by medicare
Good news...
Theralink interview...
Big news coming soon
Jump 300% or more